Drew Altman, the longtime chief executive of KFF, has announced plans to step down at the conclusion of 2024, according to reporting from The New York Times. Altman's departure marks a significant transition for one of the nation's most influential independent sources of health policy research and analysis.
During his tenure, Altman elevated KFF from a relatively obscure family foundation to a nationally recognized authority on U.S. healthcare issues. The organization has become a go-to resource for policymakers, journalists, and healthcare professionals seeking objective data and analysis on complex health policy matters ranging from insurance coverage to pharmaceutical pricing.
For Atlanta-area healthcare executives and policy professionals, KFF's research has long informed strategic discussions around Medicaid expansion, insurance market dynamics, and workforce development. The organization's influence on healthcare policy extends to state-level decisions affecting Georgia's healthcare landscape and employer-sponsored benefits.
The transition creates an opportunity for KFF's board to chart the organization's direction during a period of significant healthcare transformation. As the healthcare sector continues navigating digital innovation, value-based care models, and regulatory changes, KFF's research capacity will remain critical for Atlanta's growing healthcare and insurance industries.
